Related to U.S. Drug Manufacturing Decline Reflects Wage Gap and Regulatory Scrutiny

• Access Pharma Taps Accupac to Manufacture Oral Mucositis Therapy in North America
  
• Millipore and Roka Bioscience to Develop Molecular Tests for Biopharmaceutical Manufacturing
  
• Nycomed to Invest At Least $96M for a Manufacturing Facility in Russia
  
• China Biologic Allies with Chinese Institute to Improve Production of Plasma-Based Products
  
• Octapharma Reports on a C$4.5M Advance to Prometic Related to Long-Term Supply of Plasma Product
  
• SAFC Completes $12M Plant Expansion
  
• Novavax Taps Xcellerex to Bolster Flu Vaccine Production
  
• Alnara Selects Lonza for Commercial Manufacture of Pancreatic Insufficiency Therapy
  
• Lonza Takes Equity Stake in Ciliate-Expression System Company
  
• ArmaGen Chooses PacificGMP to Manufacture Fusion Protein for Phase I Trial in Stroke and Parkinson’s
  
• ProMetic to Provide Halozyme with Synthetic Ligand Affinity Adsorbent
  
• Talecris Pours $268.7M into Production Plant in North Carolina
  
• Novartis Inaugurates $1B U.S. Cell Culture Flu Vaccine Facility
  
• BioLife to Produce Custom Biopreservation Media for Centocor
  
• EU Gives Dynavax’ German Manufacturing Plant the Nod for Commercial Production of HBV Vaccine
  
• Patheon Consolidates Production Activities in Puerto Rico
  
• OctoPlus Signs Contract with Axentis for Inhaled CF Therapy
  
• Lonza Launches Cells on Demand Services for Cell Culture and Transfection
  
• Formatech to Fill and Finish One Lot of KAI Pharmaceuticals’ SHPT Drug at No Charge
  
• Lonza to Manufacture Micromet’s Blinatumomab BiTE Antibody